Virtual Booth

OncoRepro is an innovative cell reprogramming kit designed to simplify the establishment of reprogrammed cells from osteosarcoma cells (OS). Osteosarcoma is an aggressive bone malignancy associated with a high risk of metastasis, highlighting the need for improved research approaches to understand cancer cell behaviour and cellular reprogramming. However, conventional cell reprogramming procedures often involve multiple components, complex preparation steps, and extensive optimisation, which may limit accessibility and reproducibility. OncoRepro aims to address these challenges by integrating essential reprogramming components, including culture matrices, specialised media, growth factors, and lentiviral vectors, into a convenient kit format. The kit is intended to facilitate a more streamlined and standardised workflow for cell reprogramming in laboratory research. By reducing the complexity of preparation and component management, OncoRepro has the potential to improve research efficiency and support investigations into cellular plasticity, cancer biology, and osteogenic differentiation. This innovation may benefit researchers, academic institutions, and biotechnology laboratories by providing a practical platform for cell-based research. With further validation and optimisation, OncoRepro has the potential for future development as a scalable research tool for advancing cancer reprogramming studies.